CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

CAR-T Therapy in Lymphoma Patients With Coexisting Cardiomyopathy or Cardiac Lymphomatous Involvement

Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the management of aggressive hematologic malignancies. However, its role in patients with lymphoma and cardiac metastasis or cardiomyopathy remains undefined due to potentially life-threatening complications such as ventricular rupt...

Full description

Bibliographic Details
Main Authors: Choon Ta Ng, MBBS, Hilda M. Gonzalez Bonilla, MD, Ian Chang, MD, M. Tun Aung, MD, Jennifer J. Gile, MD, Naveen L. Pereira, MD, Jose C. Villasboas Bisneto, MD, Patrick B. Johnston, MD, Hector R. Villarraga, MD, Martin G. Rodriguez-Porcel, MD, Grace Lin, MD, Yi Lin, MD, PhD, Joerg Herrmann, MD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:JACC: Case Reports
Subjects:
CAR-T
cardiac
cardio-oncology
cardiomyopathy
lymphoma
metastasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084923001304

Internet

http://www.sciencedirect.com/science/article/pii/S2666084923001304

Similar Items